Exploring the potential of EphA2 receptor signaling pathway: a comprehensive review in cancer treatment
Molecular Biology Reports · 2024-12 · 51 (1)
DOI: 10.1007/s11033-024-09298-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, online erschienen am 23.02.2024. Verfasst von Mohd Nehal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences, Integral University, Lucknow, Uttar Pradesh, 226026, India. Hauptthemen laut MEDLINE: Receptor, EphA2, Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 83 Literaturangaben.
Abstract (Originalsprache)
The protein encoded by the ephrin type-A receptor 2 (EphA2) gene is a member of the ephrin receptor subfamily of the receptor tyrosine kinase family (RTKs). Eph receptors play a significant role in various biological processes, particularly cancer progression, development, and pathogenesis. They have been observed to regulate cancer cell growth, migration, invasion, tumor development, invasiveness, angiogenesis, and metastasis. To target EphA2 activity, various molecular, genetic, biochemical, and pharmacological strategies have been extensively tested in laboratory cultures and animal models. Notably, drugs, such as dasatinib, initially designed to target the kinase family, have demonstrated an additional capability to target EphA2 activity. Additionally, a novel monoclonal antibody named EA5 has emerged as a promising option to counteract the effects of EphA2 overexpression and restore tamoxifen sensitivity in EphA2-transfected MCF-7 cells during in vitro experiments. This antibody mimicked the binding of Ephrin A to EphA2. These methods offer potential avenues for inhibiting EphA2 activity, which could significantly decelerate breast cancer progression and restore sensitivity to certain drugs. This review article comprehensively covers EphA2's involvement in multiple malignancies, including ovarian, colorectal, breast, lung, glioma, and melanoma. Furthermore, we discuss the structure of EphA2, the Eph-Ephrin signaling pathway, various EphA2 inhibitors, and the mechanisms of EphA2 degradation. This article provides an extensive overview of EphA2's vital role in different types of cancers and outlines potential therapeutic approaches to target EphA2, shedding light on the underlying molecular mechanisms that make it an attractive target for cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biosciences, Integral University, Lucknow, Uttar Pradesh, 226026, India.
- Department of Bioengineering, Integral University, Lucknow, Uttar Pradesh, 226026, India.
- Department of Bioengineering, Integral University, Lucknow, Uttar Pradesh, 226026, India. mkakhan@iul.ac.in.
Zitieren
APA
Nehal, M., Khatoon, J., Akhtar, S., & Khan, M. K. A. (2024). Exploring the potential of EphA2 receptor signaling pathway: a comprehensive review in cancer treatment. Molecular Biology Reports, 51(1). https://doi.org/10.1007/s11033-024-09298-8
Vancouver
Nehal M, Khatoon J, Akhtar S, Khan MKA. Exploring the potential of EphA2 receptor signaling pathway: a comprehensive review in cancer treatment. Molecular Biology Reports. 2024;51(1). doi:10.1007/s11033-024-09298-8
BibTeX
@article{Nehal2024,
author = {Nehal, Mohd and Khatoon, Jahanarah and Akhtar, Salman and Khan, Mohammad Kalim Ahmad},
title = {Exploring the potential of EphA2 receptor signaling pathway: a comprehensive review in cancer treatment},
journal = {Molecular Biology Reports},
year = {2024},
volume = {51},
number = {1},
doi = {10.1007/s11033-024-09298-8}
}
EUVIMED